Riskpilot← Back to searchSign inGet full accessPHARMAERO ApS
APSDissolvedCVR 32827942Møllevænget 36Manufacture of pharmaceutical preparations · NACE 2120Est. 20101 employees
Revenue 2023
DKK -19K
-97% vs 2022
EBITDA margin
100.0%
+97% vs 2022
Equity ratio
64.2%
Financial strength
Net profit 2023
DKK -20K
+97% vs 2022
| Revenue | DKK -19K | -97% |
| EBITDA | DKK -19K | +97% |
| Net profit | DKK -20K | +97% |
| Total assets | DKK 81K | -14% |
| Equity | DKK 52K | -28% |
| Employees | 1 | — |
Legal name
PHARMAERO ApS
CVR number
32827942
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
11. marts 2010
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør.
Address
Møllevænget 36
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 29 | 149 | 0 | -638 | -19 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -14.001 | -2.096 | -1.266 | -638 | -19 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -14.001 | -2.096 | -1.266 | -638 | -19 |
| Net financials | -58 | -34 | -31 | -12 | -1 |
| Profit before tax | -14.059 | -2.130 | -1.297 | -651 | -20 |
| Tax | -1.828 | -356 | -0 | -0 | -0 |
| Net profit | -12.231 | -1.774 | -1.297 | -651 | -20 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 7.209 | 5.260 | 3.534 | 94 | 81 |
| Equity | 6.586 | 4.812 | 3.516 | 72 | 52 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 623 | 448 | 18 | 22 | 29 |
| Total debt | 623 | 448 | 18 | 22 | 29 |
EBITDA margin
-1861500.0%
This company
15.8%
Market median
-11781746% vs market
20192023
Equity ratio
64.2%
This company
38.2%
Market median
+68% vs market
20192023
Return on equity
-38.7%
This company
18.4%
Market median
-310% vs market
20192023
Net profit margin
-2007200.0%
This company
8.1%
Market median
-24780347% vs market
20192023
Asset turnover
-0.23×
This company
1.12×
Market median
-121% vs market
20192023
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20192023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
SH Founder | Founder | 2010 – 2025 |
TN Management | Management | 2020 – 2025 |
PC Management | Management | 2017 – 2018 |
| Name | Role | Member since |
|---|---|---|
| Former (8) | ||
| Chairman | 2020 – 2022 | |
| Board of Directors | 2017 – 2022 | |
| Board of Directors | 2010 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2010 – 2017 | |
| Chairman | 2010 – 2020 | |
| Board of Directors | 2010 – 2022 | |
| Board of Directors | 2018 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2022 | |
| Individual | 50–66.65% | 50–66.65% | 2018 | |
| Company | 50–66.65% | 50–66.65% | 2014 | |
| Individual | 50–66.65% | 50–66.65% | 2014 | |
| Individual | 50–66.65% | 50–66.65% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PHARMAERO ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| SCANDINAVIAN HEALTH LIMITED | Founder | 0 companies |
| Tomas Norling | Management | 0 companies |
| Pietro Crovetto | Management | 0 companies |
| Markus Puusepp | Chairman | 0 companies |
| Per Martin Linse | Board of Directors | 0 companies |
| Carl-Åke Carlsson | Board of Directors | 0 companies |
| Robert Weeden Irish | Board of Directors | 0 companies |
| Hans Lennart Svanborg | Board of Directors | 0 companies |
| Mats Persson | Chairman | 0 companies |
| Aleksandar Danilovski | Board of Directors | 0 companies |
| Mikkel Lyager Olsen | Board of Directors | 0 companies |